Relative effectiveness of bivalent boosters against severe COVID-19 outcomes among people aged ≥ 65 years in Finland, September 2022 to August 2023
| dc.contributor.author | Poukka, Eero | |
| dc.contributor.author | Perälä, Jori | |
| dc.contributor.author | Nohynek, Hanna | |
| dc.contributor.author | Goebeler, Sirkka | |
| dc.contributor.author | Auranen, Kari | |
| dc.contributor.author | Leino, Tuija | |
| dc.contributor.author | Baum, Ulrike | |
| dc.contributor.organization | fi=kliininen laitos|en=Department of Clinical Medicine| | |
| dc.contributor.organization | fi=tilastotiede|en=Statistics| | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.42133013740 | |
| dc.converis.publication-id | 458373533 | |
| dc.converis.url | https://research.utu.fi/converis/portal/Publication/458373533 | |
| dc.date.accessioned | 2025-08-27T22:33:43Z | |
| dc.date.available | 2025-08-27T22:33:43Z | |
| dc.description.abstract | <p><b>Background:</b> Long-term effectiveness data on bivalent COVID-19 boosters are limited.</p><p><b>Aim:</b> We evaluated the long-term protection of bivalent boosters against severe COVID-19 among >= 65-year-olds in Finland.</p><p><b>Methods:</b> In this register-based cohort analysis, we compared the risk of three severe COVID-19 outcomes among >= 65-year-olds who received a bivalent booster (Original/Omicron BA.1 or Original/BA.4-5; exposed group) between 1/9/2022 and 31/8/2023 to those who did not (unexposed). We included individuals vaccinated with at least two monovalent COVID-19 vaccine doses before 1/9/2022 and >= 3months ago. The analysis was divided into two periods: 1/9/2022-28/2/2023 (BA.5 and BQ.1.X predominating) and 1/3/2023- 31/8/2023 (XBB predominating). The hazards for the outcomes between exposed and unexposed individuals were compared with Cox regression.</p><p><b>Results:</b> We included 1,191,871 individuals. From 1/9/2022 to 28/2/2023, bivalent boosters were associated with a reduced risk of hospitalisation due to COVID19 (hazard ratio (HR):0.45; 95% confidence interval (CI):0.37-0.55), death due to COVID-19 (HR:0.49; 95%CI:0.38-0.62), and death in which COVID-19 was a contributing factor (HR:0.40; 95%CI:0.31-0.51) during 14-60days since vaccination. From 1/3/2023 to 31/8/2023, bivalent boosters were associated with lower risks of all three severe COVID-19 outcomes during 61-120days since a bivalent booster (e.g. HR:0.53; 95% CI: 0.39-0.71 for hospitalisation due to COVID-19); thereafter no notable risk reduction was observed. No difference was found between Original/Omicron BA.1 and Original/BA.4-5 boosters.</p><p><b>Conclusion:</b> Bivalent boosters initially reduced the risk of severe COVID-19 outcomes by ca 50% among >= 65-year-olds, but protection waned over time. These findings help guide vaccine development and vaccination programmes.</p> | |
| dc.identifier.eissn | 1560-7917 | |
| dc.identifier.jour-issn | 1025-496X | |
| dc.identifier.olddbid | 202380 | |
| dc.identifier.oldhandle | 10024/185407 | |
| dc.identifier.uri | https://www.utupub.fi/handle/11111/46933 | |
| dc.identifier.url | https://doi.org/10.2807/1560-7917.ES.2024.29.37.2300587 | |
| dc.identifier.urn | URN:NBN:fi-fe2025082785701 | |
| dc.language.iso | en | |
| dc.okm.affiliatedauthor | Auranen, Kari | |
| dc.okm.affiliatedauthor | Dataimport, Kliinisen laitoksen yhteiset | |
| dc.okm.discipline | 3111 Biomedicine | en_GB |
| dc.okm.discipline | 3142 Public health care science, environmental and occupational health | en_GB |
| dc.okm.discipline | 3111 Biolääketieteet | fi_FI |
| dc.okm.discipline | 3142 Kansanterveystiede, ympäristö ja työterveys | fi_FI |
| dc.okm.internationalcopublication | not an international co-publication | |
| dc.okm.internationality | International publication | |
| dc.okm.type | A1 ScientificArticle | |
| dc.publisher | EUR CENTRE DIS PREVENTION & CONTROL | |
| dc.publisher.country | Sweden | en_GB |
| dc.publisher.country | Ruotsi | fi_FI |
| dc.publisher.country-code | SE | |
| dc.publisher.place | STOCKHOLM | |
| dc.relation.articlenumber | 2300587 | |
| dc.relation.doi | 10.2807/1560-7917.ES.2024.29.37.2300587 | |
| dc.relation.ispartofjournal | Eurosurveillance | |
| dc.relation.issue | 37 | |
| dc.relation.volume | 29 | |
| dc.source.identifier | https://www.utupub.fi/handle/10024/185407 | |
| dc.title | Relative effectiveness of bivalent boosters against severe COVID-19 outcomes among people aged ≥ 65 years in Finland, September 2022 to August 2023 | |
| dc.year.issued | 2024 |
Tiedostot
1 - 1 / 1